[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73437]], camposKey:0014-2972 2023-01-01 Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID-19 pneumonia: An open-label randomised trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73438]], camposKey:1471-2261 2021-12-01 Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78891]], camposKey:1699-695X 2021-01-01 Utilidad del índice de comorbilidad de Charlson en personas ancianas. Concordancia con otros índices de comorbilidad6470, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41015]], camposKey:0785-3890 2018-01-01 Relationship between the FRAX index and physical and cognitive functioning in older people538543, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41014]], camposKey:1742-7835 2018-01-01 Role of Bone Morphogenetic Protein 2 Polymorphisms in Bone Mineral Density after the Start of Treatment with Atorvastatin766769, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=57021]], camposKey:2147-9720 2016-01-01 Relationship among angiotensin-converting enzyme polymorphism, cardiovascular risk, and osteoporotic fractures1012, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73439]], camposKey:0300-2896 2015-03-01 Atypical deep venous thrombosis as the first manifestation of pulmonary neoplasm Trombosis venosa inusual como primera manifestación de neoplasia pulmonar156157, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=16763]], camposKey:2173-2345 2015-01-01 Polimorfismo A986S del receptor sensor del calcio y fracturas clínicas osteoporóticas.610, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=16762]], camposKey:0300-2896 2015-01-01 Trombosis venosa inusual como primera manifestación de neoplasia pulmonar156157, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41025]], camposKey:0172-8172 2014-01-01 Polymorphisms of the farnesyl diphosphate synthase gene modulate bone changes in response to atorvastatin10731077, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38119]], camposKey:0167-5273 2010-01-01 Levels of DKK1 in patients with acute myocardial infarction and response to atorvastatin164165, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38117]], camposKey:1687-8337 2010-01-01 Vitamin D levels and lipid response to atorvastatin00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30757]], camposKey:0918-8959 2009-01-01 Atorvastatin and BMD in Coronary Syndrome. Role of Lys656Asn Polymorphism of Leptin Receptor Gene221225, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38154]], camposKey:0167-5273 2008-01-01 Bone mineral density, bone remodeling and osteoprotegerin in patients with acute coronary syndrome144145, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40864]], camposKey:1128-3602 2008-01-01 Effect of atorvastatin on bone mineral density in patients with acute coronary syndrome8388, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38152]], camposKey:0250-6807 2008-01-01 Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome117121, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40869]], camposKey:1297-319X 2007-01-01 Effect of ß-blockers on bone mass and biomechanical parameters of the femoral neck in males with acute myocardial infarction259262, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40870]], camposKey:0002-9149 2007-01-01 Effects of Atorvastatin on Vitamin D Levels in Patients With Acute Ischemic Heart Disease903905, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56857]], camposKey:1169-8330 2007-01-01 Effet des bêtabloquants sur la masse osseuse et les propriétés biomécaniques du col fémoral après un infarctus du myocarde chez les malades de sexe masculin475478, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40866]], camposKey:0250-6807 2007-01-01 Ghrelin and bone mass in postmenopausal hypertensive women223227, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40874]], camposKey:1573-4129 2006-01-01 Effects of statins on bone markers bone mineral density and fractures. Possible role in osteoporosis treatment161168, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41047]], camposKey:1537-064X 2005-01-01 Effect of atorvastatin to RANKL/OPG system in patients with acute coronary syndrome569574, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37596]], camposKey:0210-0010 2004-10-01 Primary central nervous system lymphoma and Creutzfeldt-Jakob disease Linfoma primario del sistema nervioso central y enfermedad de Creutzfeldt-Jakob00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73440]], camposKey:0212-7199 2004-01-01 Intoxication with tyroxine. Clinical manifestations and therapeutical approach Intoxicacíon con levotiroxina: Manifestaciones clínicas y manejo terapéutico3941, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=16761]], camposKey:0210-0010 2004-01-01 Linfoma primario del sistema nervioso central y enfermedad de Creutzfeldt-Jakob6950, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73441]], camposKey:0014-2565 2002-01-01 Dapsona syndrome [4]00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41063]], camposKey:0014-2565 2002-01-01 Dapsona syndrome [4]414414, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38237]], camposKey:0301-0163 2002-01-01 Light symptoms following a high-dose intentional l-thyroxine ingestion treated with cholestyramine6163][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30226]]][][][][][][][][][][][][][][][][][][][][][][][][][]